INmune Bio Inc. INMB
1.38 USD +0.06 (+4.55%)
Nov 4, 2026, 9:49 AM EST
1.35 Day range 1.37
1.09 52-week range 2.60
- YTD
- -11.54%
- 1 year
- -19.77%
Analyst view
Price target (mean) 19.83 +1337.2% upside
Now 1.38
- Target (low)
- 16.00
- Target (mean)
- 19.83
- Target (high)
- 22.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy3
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.556 | -0.66 – -0.45 | -0.47 | -18.3% | 0 | -100.0% | 5 |
| Next quarter | -0.47 | -0.47 – -0.47 | -0.61 | +23.0% | 0 | -100.0% | 2 |
| Current year | -2.30 | -2.53 – -2.15 | -1.67 | -37.5% | 9.33K | -94.0% | 5 |
| Next year | -2.04 | -2.39 – -1.54 | -2.30 | +11.0% | 0 | -100.0% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 1, 2023 | Baird | Initiated | — | Outperform |
| May 24, 2022 | BTIG | Maintained | — | Buy |
| May 24, 2022 | B. Riley Securities | Downgrade | Buy | Neutral |
| Jan 24, 2022 | B. Riley Securities | Maintained | — | Buy |
| Apr 21, 2021 | B. Riley Securities | Initiated | — | Buy |
| Nov 9, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Sep 1, 2020 | BTIG | Initiated | — | Buy |
| Jul 15, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| May 15, 2020 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 12, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Dec 19, 2019 | Roth Capital | Initiated | — | Buy |
| Aug 21, 2019 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 19, 2019 | Maxim Group | Initiated | — | Buy |